Access to anti-retroviral drugs, female in Central African Republic

Central African Republic: Access to anti-retroviral drugs, female was 73.0% in 2024. ◆ Volatile

Latest (2024)
73.0%
Change on year
up 2.8%
World rank
71st
of 141 countries
All-time high
73.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Central African Republic, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 0 %2003: 0 %2004: 0 %2005: 1 %2006: 2 %2007: 4 %2008: 8 %2009: 9 %2010: 11 %2011: 11 %2012: 13 %2013: 12 %2014: 20 %2015: 24 %2016: 35 %2017: 40 %2018: 43 %2019: 52 %2020: 55 %2021: 62 %2022: 67 %2023: 71 %2024: 73 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, female in Central African Republic is 73.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 2.8% on the previous year and up 265.0% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Central African Republic peaked at 73.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Central African Republic 71st out of 141 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Central African Republic, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Central African Republic, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 1.0%
2006 2.0% +100.0%
2007 4.0% +100.0%
2008 8.0% +100.0%
2009 9.0% +12.5%
2010 11.0% +22.2%
2011 11.0% +0.0%
2012 13.0% +18.2%
2013 12.0% -7.7%
2014 20.0% +66.7%
2015 24.0% +20.0%
2016 35.0% +45.8%
2017 40.0% +14.3%
2018 43.0% +7.5%
2019 52.0% +20.9%
2020 55.0% +5.8%
2021 62.0% +12.7%
2022 67.0% +8.1%
2023 71.0% +6.0%
2024 73.0% +2.8%

Central African Republic compared with similar countries

  • Central African Republic's 73.0% is below the median for low income countries, which is 75.5%, 97% of the median. (24 countries reporting)
  • Central African Republic's 73.0% is below the median for Sub-Saharan Africa, which is 88.5%, 82% of the median. (44 countries reporting)

Biggest year-on-year movements

Years where Access to anti-retroviral drugs, female in Central African Republic changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2006 +100.0% 1.0% 2.0%
2007 +100.0% 2.0% 4.0%
2008 +100.0% 4.0% 8.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 2.4% 0.0% 9.0% 10
2010s 26.1% 11.0% 52.0% 10
2020s 65.6% 55.0% 73.0% 5

Countries ranked near Central African Republic

  1. 69 Comoros 74.0% compare
  2. 69 El Salvador 74.0% compare
  3. 71 Bahrain 73.0% compare
  4. 71 Guatemala 73.0% compare
  5. 71 Mali 73.0% compare
  6. 71 Sri Lanka 73.0% compare

See the full ranking of 160 places →

More gender data for Central African Republic

All data for Central African Republic →

Frequently asked questions

What is access to anti-retroviral drugs, female in Central African Republic?
Access to anti-retroviral drugs, female in Central African Republic was 73.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Central African Republic?
The highest recorded value was 73.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Central African Republic?
The lowest recorded value was 0.0% in 2000.
How does Central African Republic rank for access to anti-retroviral drugs, female?
Central African Republic ranks 71st out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Central African Republic?
Over the last ten years it is up 265.0%. The long-run trend across the full record is volatile.
Where does this Central African Republic data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Central African Republic. Statizoid, drawing on UNAIDS estimates. Retrieved 13 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/central-african-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/central-african-republic/">Access to anti-retroviral drugs, female in Central African Republic</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.